Schrödinger Company
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 400 employees and is engaged with customers and collaborators in more than 70 countries. To learn more visit www.schrodinger.com.
Investors
%20.jpg)
Total Funding:
567224987.0
Acquisitions Number:
NA
Headquarters:
New York, New York, United States
Funding Status:
IPO
Zip:
NA
Employee Number:
251-500
Estimated Revenue:
$50M to $100M
Last Funding Type:
Grant
Number Of Exists:
1
Investor Type:
IPO
Last Funding Date:
2021-11-18
Investors Number:
16.0
Founded Date:
1990-08-16
Industry:
Early Drug Development